Orthofix(OFIX) ZACKS·2024-11-07 14:30Company Performance - Orthofix reported quarterly earnings of $0.07 per share, surpassing the Zacks Consensus Estimate of a loss of $0.14 per share, representing an earnings surprise of 150% [1] - The company posted revenues of $196.61 million for the quarter ended September 2024, aligning with the Zacks Consensus Estimate and showing an increase from $184.01 million year-over-year [2] - Over the last four quarters, Orthofix has exceeded consensus EPS estimates three times and topped consensus revenue estimates three times [2] Stock Movement and Outlook - Orthofix shares have increased approximately 36.5% since the beginning of the year, outperforming the S&P 500's gain of 24.3% [3] - The sustainability of the stock's price movement will depend on management's commentary during the earnings call and future earnings expectations [3][4] - The current consensus EPS estimate for the upcoming quarter is $0.11 on revenues of $212.65 million, while for the current fiscal year, it is -$0.32 on revenues of $796.45 million [7] Industry Context - The Medical - Instruments industry, to which Orthofix belongs, is currently ranked in the top 25% of over 250 Zacks industries, indicating a favorable outlook [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can impact stock performance [5][6]